Innolake Pharmaceuticals (Hangzhou)
A clinical stage biotech company, dedicated to developing innovative medicines against cancer and autoimmune diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$55—83m (Dealroom.co estimates Jun 2023.)
小营街道 Zhejiang (HQ)
Authorizing premium user...